Perspective Therapeutics (CATX) Inventory Average (2011 - 2023)

Perspective Therapeutics has disclosed Inventory Average across 12 years of filings, most recently posting $1.1 million for Q3 2023.

• Inventory Average for Q3 2023 came in at $1.1 million, down 28.55% year-over-year; the trailing twelve-month figure through Sep 2023 was $1.1 million (down 28.55% YoY), and the FY2022 annual result was $1.4 million, changed N/A from the prior year.
• Inventory Average came in at $1.1 million for Q3 2023 at Perspective Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.5 million in Q4 2022 to a low of $513500.0 in Q1 2019.
• The 5-year median for Inventory Average is $855500.0 (2021), against an average of $908184.2.
• Across the five-year window, Inventory Average jumped 62.94% in 2021 and decreased 28.55% in 2023, its largest moves.
• Perspective Therapeutics' Inventory Average stood at $523000.0 in 2019, then grew by 24.86% to $653000.0 in 2020, then surged by 62.94% to $1.1 million in 2021, then surged by 39.19% to $1.5 million in 2022, then slipped by 28.87% to $1.1 million in 2023.
• The last three Inventory Average figures came in at $1.1 million (Q3 2023), $1.3 million (Q2 2023), and $1.4 million (Q1 2023), per Business Quant data.